After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q4 2021 call → NOWe need to determine if management reports that the most important positive developments happened so late in the period or shortly after it ended that the results contain little or none of their effect, with management marking the timing. Look for both halves: (1) late-breaking concrete positive events with timing anchored by management, and (2) management treats them as the real story the numbers missed. Scan the transcript. Management discusses various developments: HRD solution, partnerships, CarePath, DEEP-Lung-IV study, etc. They mention signing new customers, partnerships like Ambry Genetics (letter of intent), AstraZeneca partnership, GE partnership. They also mention "expecting several signed agreements with Tier 1 institutions in the coming months" - that's future. They mention "we recently announced onboarding a leading Taiwanese genetic testing company SOFIVA GENOMICS" - that's recent, but not necessarily late in period. They mention "we recently announced that we signed a letter of intent with Ambry Genetics" - that's a letter of intent, not a concrete contract. They mention "we recently announced the partnership with AstraZeneca" - that's a partnership, but timing? They say "In line with the strong traction we are already seeing with the solution, we recently announced the partnership with AstraZeneca" - that's recent, but not specifically late in the quarter or after. Look for explicit timing like "late in the quarter" or "since quarter-end". I don't see such explicit phrasing. Management talks about "strong finish on the fourth quarter" but that's general. They mention "we are expecting several signed agreements with Tier 1 institutions in the coming months" - that's future, not late-breaking. They mention "we recently appointed Ken Freedman" - that's a hire, not a business event. They mention "we recently introduced CarePath at J.P. Morgan Healthcare Conference in January" - that's after the period (Q4 ended Dec 31, 2021; January is after). But is that a concrete positive event? It's a product launch, but they say "we expect to unveil several exciting new products later this year" - so CarePath is introduced, but not yet commercialized. They also mention DEEP-Lung-IV study launched in November (within Q4) and they have 16 sites signed up, but that's a study, not a revenue-generating event.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...